Literature DB >> 23174719

Serum lipid profile in oral cancer and leukoplakia: correlation with tobacco abuse and histological grading.

Priya Kumar1, J Augustine, Aadithya B Urs, Shelly Arora, Shalini Gupta, Vikrant R Mohanty.   

Abstract

INTRODUCTION: Role of alterations in serum lipid profile in oral cancer remains controversial. The present study aimed to evaluate the implications of altered serum lipid profile in patients with oral cancer (OC), oral leukoplakia (OLP), and tobacco habits.
MATERIALS AND METHODS: Thirty patients with OC, 30 with OLP, 30 tobacco abusers (TAs), and 30 age and sex matched healthy controls were included in the study. Serum lipid profile including total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL), Very low density lipoprotein (VLDL), and triglycerides (Tg) were evaluated using a fully automatic Biochemistry analyzer. Difference in lipid profile in various types of TA, that is, smokeless tobacco (SLT), smoking tobacco (ST), and a combination (Comb) usage of both forms were also analyzed.
RESULTS: TC, HDL, and LDL were much lower in the OC group compared with control. Although these parameters were low in the OPC group compared with controls, the difference was not significant. On histological analysis, TC and HDL were found to decrease marginally with loss of tumor differentiation in OC. No correlation was found between the mean serum lipid profiles and degree of dysplasia in OLP. TC and HDL were significantly lesser in all forms of TA when compared with control.
CONCLUSIONS: There may be an inverse relationship between serum lipid profile and OC. No significant reduction in lipid profile was observed in the OLP group. This may indicate that hypolipidemia is a late change occurring during carcinogenesis or is an effect rather than the cause of cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23174719     DOI: 10.4103/0973-1482.103517

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  8 in total

1.  Alteration of Serum Lipid in Oral Sub Mucous Fibrosis in Central India.

Authors:  J K Yashveer; Devendra Pankaj
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-06-28

2.  Evaluation and correlation of serum lipid profile in oral and gastrointestinal cancer patients.

Authors:  G Vijay Srinivas; Srilekha Namala; Anuradha Ananthaneni; H K Puneeth; B Sabitha Devi
Journal:  J Int Oral Health       Date:  2013-12-26

3.  Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient Survival.

Authors:  Ronald C Eldridge; Karan Uppal; D Neil Hayes; M Ryan Smith; Xin Hu; Zhaohui S Qin; Jonathan J Beitler; Andrew H Miller; Evanthia C Wommack; Kristin A Higgins; Dong M Shin; Bryan Ulrich; David C Qian; Nabil F Saba; Deborah W Bruner; Dean P Jones; Canhua Xiao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-08-10       Impact factor: 4.254

4.  Diagnostic significance of serum and salivary lipid levels in oral precancer and oral cancer.

Authors:  Vandana Singh; Ranjitkumar Patil; Subash Singh; Anurag Tripathi; Vikram Khanna; Wahid Ali
Journal:  Natl J Maxillofac Surg       Date:  2021-07-15

5.  Alteration of Lipid Profile in Patients with Head and Neck Malignancy.

Authors:  Vijay Kumar Poorey; Pooja Thakur
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-01-30

6.  Estimation of serum lipids in patients with Oral Submucous Fibrosis in India.

Authors:  Kratika Ajai; Sunil R Panat; Ashish Aggarwal; Nupur Agarwal; Nitin Upadhyay; Anuja Joshi
Journal:  J Clin Exp Dent       Date:  2014-07-01

7.  Analysis of lipid profile in cancer patients, smokers, and nonsmokers.

Authors:  A Vikramsimha Reddy; Lakshmi Keerthana Killampalli; A Ravi Prakash; Sushma Naag; G Sreenath; Sunil Kumar Biraggari
Journal:  Dent Res J (Isfahan)       Date:  2016 Nov-Dec

8.  Fatty acids distribution and content in oral squamous cell carcinoma tissue and its adjacent microenvironment.

Authors:  Ludmiła Halczy-Kowalik; Arleta Drozd; Ewa Stachowska; Radosław Drozd; Tomasz Żabski; Wenancjusz Domagała
Journal:  PLoS One       Date:  2019-06-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.